Access cutting-edge melanoma treatment through this clinical trial at a research site in Chandler. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Chandler at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called "study drugs". The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the combination of fianlimab and cemiplimab is in treating melanoma, in comparison with the combination of two medications, relatlimab and nivolumab, commercialized under the bra
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this melanoma clinical trial in Chandler, AZ
If you're searching for melanoma treatment options in Chandler, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chandler research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.